Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEXO.L Regulatory News (EXO)

  • There is currently no data for EXO

Acquisition

11 Apr 2017 15:30

RNS Number : 2115C
Exova Group PLC
11 April 2017
Β 

Β 

STOCK EXCHANGE RELEASE

Β 

11 April 2017

Exova Group plc

Β 

Exova acquires SL Pharma Labs Incorporated

Β 

Exova Group plc ("Exova") EXO.L, the global testing, calibration and advisory services provider, has acquired SL Pharma Labs Incorporated (SL Pharma), a Delaware, US, based business that provides laboratory and clinical manufacture testing services to pharmaceutical, biotechnology and medical device companies.

Founded in 1997, SL Pharma has built a strong reputation in the provision of high value and high quality pharmaceutical product development and testing services focused primarily on the development and clinical manufacture of parenteral, ophthalmic, intranasal and topical drug products. The business has a team of 14 specialists and achieved revenues of around $2.5m in 2016.

Ian El-Mokadem, Chief Executive Officer at Exova, said: "This acquisition complements our existing operations by enhancing Exova's technical expertise in pharmaceutical services and offers a great foundation for further growth in North America. SL Pharma's addition to our portfolio clearly demonstrates our commitment to providing more technically demanding services and developing our capabilities in new markets."

Β 

ENDS

Β 

Β 

Enquiries:

Β 

Andy Jones

Powerscourt

T: +44 (0) 20 7549 0747

E: andy.jones@exova.com

Β 

Andrew Pickup

Corporate Affairs Director, Exova Group plc

T: +44 (0) 7920 243 393

E: andrew.pickup@exova.com

Exova

Β 

Exova is one of the world's leading laboratory-based testing groups, trusted by organisations to test and advise on the safety, quality and performance of their products and operations. Headquartered in Edinburgh, UK, Exova operates 135 laboratories and offices in 33 countries and employs around 4,200 people throughout Europe, the Americas, the Middle East, Asia/Asia Pacific and Africa.

Exova's capabilities help to extend asset life, bring predictability to applications, and shorten the time to market for customers' products, processes and materials. With over 90 years' experience, Exova specialises in testing across a number of key sectors ranging from Aerospace to Fire & Building Products; Oil & Gas and Industrials; Infrastructure & Environment; Transportation; and Health Sciences.

Exova Group plc is registered in England (registration number 08907086). Its legal entity identifier ('LEI') number is 213800BFE317FGSYMZ19.

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
ACQBBGDSSGBBGRB
Date   Source Headline
28th Mar 201711:45 amRNSForm 8.5 (EPT/RI) Exova Group Plc
28th Mar 201711:16 amRNSForm 8.5 (EPT/RI)
28th Mar 201711:00 amRNSForm 8.5 (EPT/RI)
28th Mar 201710:33 amRNSForm 8.3 - Exova Group plc
28th Mar 20177:00 amBUSForm 8.3 - Exova Group Plc
27th Mar 20173:12 pmBUSForm 8.3 - Exova Group Plc
27th Mar 20173:05 pmRNSForm 8.3 - Exova Group Plc
27th Mar 201710:37 amRNSForm 8.3 - Exova Group PLC
27th Mar 20179:15 amRNSRule 2.9 Announcement
27th Mar 20177:00 amRNSPossible Offer for Exova Group plc
28th Feb 20177:00 amRNSFinal Results
12th Jan 20177:00 amRNSPost-close Trading Update
21st Dec 201612:06 pmRNSChanges to Nomination Committee
6th Dec 20167:02 amRNSDevelopment of global laboratory portfolio
1st Dec 20163:15 pmRNSVoting Rights and Capital
29th Nov 20169:00 amRNSDirector/PDMR Shareholding
24th Nov 20169:00 amRNSIssue of Equity
24th Nov 20169:00 amRNSDirector/PDMR Shareholding
24th Nov 20167:00 amRNSDivisional Reporting of Historic Results
24th Nov 20167:00 amRNSTrading Statement
27th Oct 20164:35 pmRNSPrice Monitoring Extension
24th Oct 20168:51 amRNSTR-1: Notification of Major Interest in Shares
21st Oct 20169:27 amRNSTR-1: Notification of Major Interest in Shares
4th Oct 20164:35 pmRNSPrice Monitoring Extension
21st Sep 20167:00 amRNS2016 Capital Markets Day
13th Sep 20169:00 amRNSTR-1: Notification of Major Interest in Shares
31st Aug 20167:00 amRNSHalf-year Report
21st Jul 20164:40 pmRNSSecond Price Monitoring Extn
21st Jul 20164:35 pmRNSPrice Monitoring Extension
4th Jul 20167:00 amRNSExova acquires Jones Environmental Forensics
1st Jul 20167:00 amRNSExova completes sale of Food, Water & Pharma Biz
29th Jun 20163:07 pmRNSNotice of Results and Capital Markets Day
28th Jun 20164:40 pmRNSSecond Price Monitoring Extn
28th Jun 20164:35 pmRNSPrice Monitoring Extension
1st Jun 20168:00 amRNSDirector Declaration
19th May 20161:46 pmRNSResult of AGM
19th May 20161:39 pmRNSAGM Statement
19th May 20167:00 amRNSExova sells UK & Ire Food, Water & Pharma Business
19th May 20167:00 amRNSTrading Update
10th May 20169:00 amRNSDirector/PDMR Shareholding
5th May 201610:00 amRNSIssue of Equity
5th May 201610:00 amRNSDirector/PDMR Shareholding
22nd Apr 20162:00 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
19th Apr 20162:00 pmRNSDirector/PDMR Shareholding
11th Apr 20169:43 amRNSAnnual Report & Accounts 2015 & Notice of 2016 AGM
1st Apr 20169:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
9th Mar 20169:00 amRNSDirector/PDMR Shareholding
7th Mar 20169:00 amRNSDirector/PDMR Shareholding
3rd Mar 20167:00 amRNSFinal Results
18th Feb 201610:16 amRNSDisclosure of Home Member State

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.